• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

客观、定量、数据驱动的化学探针评估。

Objective, Quantitative, Data-Driven Assessment of Chemical Probes.

机构信息

Cancer Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, London SM2 5NG, UK; Department of Data Science, The Institute of Cancer Research, 15 Cotswold Road, London SM2 5NG, UK.

Department of Data Science, The Institute of Cancer Research, 15 Cotswold Road, London SM2 5NG, UK.

出版信息

Cell Chem Biol. 2018 Feb 15;25(2):194-205.e5. doi: 10.1016/j.chembiol.2017.11.004. Epub 2017 Dec 14.

DOI:10.1016/j.chembiol.2017.11.004
PMID:29249694
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5814752/
Abstract

Chemical probes are essential tools for understanding biological systems and for target validation, yet selecting probes for biomedical research is rarely based on objective assessment of all potential compounds. Here, we describe the Probe Miner: Chemical Probes Objective Assessment resource, capitalizing on the plethora of public medicinal chemistry data to empower quantitative, objective, data-driven evaluation of chemical probes. We assess >1.8 million compounds for their suitability as chemical tools against 2,220 human targets and dissect the biases and limitations encountered. Probe Miner represents a valuable resource to aid the identification of potential chemical probes, particularly when used alongside expert curation.

摘要

化学探针是理解生物系统和验证靶标的重要工具,但在选择用于生物医学研究的探针时,很少基于对所有潜在化合物的客观评估。在这里,我们描述了 Probe Miner:Chemical Probes Objective Assessment 资源,利用大量的公共药物化学数据来对化学探针进行定量、客观、数据驱动的评估。我们评估了超过 180 万个化合物,以确定它们作为针对 2220 个人类靶标的化学工具的适用性,并剖析了遇到的偏见和局限性。Probe Miner 是一个有价值的资源,可以帮助识别潜在的化学探针,特别是与专家策展一起使用时。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f20/5814752/27301219e9d0/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f20/5814752/097b49b84211/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f20/5814752/235536c7ad67/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f20/5814752/d101c036f8aa/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f20/5814752/44800466669f/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f20/5814752/02ec672790ff/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f20/5814752/27301219e9d0/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f20/5814752/097b49b84211/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f20/5814752/235536c7ad67/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f20/5814752/d101c036f8aa/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f20/5814752/44800466669f/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f20/5814752/02ec672790ff/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f20/5814752/27301219e9d0/gr5.jpg

相似文献

1
Objective, Quantitative, Data-Driven Assessment of Chemical Probes.客观、定量、数据驱动的化学探针评估。
Cell Chem Biol. 2018 Feb 15;25(2):194-205.e5. doi: 10.1016/j.chembiol.2017.11.004. Epub 2017 Dec 14.
2
Public resources for chemical probes: the journey so far and the road ahead.化学探针公共资源:一路走来与展望未来。
Future Med Chem. 2021 Apr;13(8):731-747. doi: 10.4155/fmc-2019-0231. Epub 2019 Nov 28.
3
The Chemical Probes Portal - 2024: update on this public resource to support best-practice selection and use of small molecules in biomedical research.化学探针门户网站 - 2024:这一公共资源的更新,以支持生物医学研究中小分子的最佳实践选择和使用。
Nucleic Acids Res. 2025 Jan 6;53(D1):D1663-D1669. doi: 10.1093/nar/gkae1062.
4
Data-Driven Exploration of Selectivity and Off-Target Activities of Designated Chemical Probes.基于数据驱动的靶向化学探针选择性和脱靶活性的探索。
Molecules. 2018 Sep 23;23(10):2434. doi: 10.3390/molecules23102434.
5
Chemical probes for biological systems.生物系统用化学探针
Drug Discov Today. 2011 Feb;16(3-4):99-106. doi: 10.1016/j.drudis.2010.11.004. Epub 2010 Nov 18.
6
The Chemical Probes Portal: an expert review-based public resource to empower chemical probe assessment, selection and use.化学探针门户:一个基于专家评审的公共资源,旨在增强化学探针评估、选择和使用的能力。
Nucleic Acids Res. 2023 Jan 6;51(D1):D1492-D1502. doi: 10.1093/nar/gkac909.
7
Probes &Drugs portal: an interactive, open data resource for chemical biology.探针与药物门户:一个用于化学生物学的交互式开放数据资源。
Nat Methods. 2017 Jul 28;14(8):759-760. doi: 10.1038/nmeth.4365.
8
Advances at the intersection of chemical biology and medicinal chemistry.化学生物学与药物化学交叉领域的进展。
Future Med Chem. 2015;7(16):2089-90. doi: 10.4155/fmc.15.151.
9
The Promise and Peril of Chemical Probe Negative Controls.化学探针阴性对照的承诺与危险。
ACS Chem Biol. 2021 Apr 16;16(4):579-585. doi: 10.1021/acschembio.1c00036. Epub 2021 Mar 21.
10
Computational chemical biology: identification of small molecular probes that discriminate between members of target protein families.计算化学生物学:鉴定小分子探针,以区分靶蛋白家族成员。
Chem Biol Drug Des. 2012 Apr;79(4):369-75. doi: 10.1111/j.1747-0285.2011.01297.x. Epub 2012 Jan 30.

引用本文的文献

1
Appendage- and Scaffold-Diverse Electrophilic and Photoreactive Probes for Integrated Phenotypic Screening-Target Identification Campaigns via a Minimalist Bifunctional Isocyanide.通过简约双功能异氰化物用于综合表型筛选-靶点鉴定活动的附肢和支架多样化亲电和亲光反应性探针。
ACS Omega. 2024 Oct 2;9(41):42557-42570. doi: 10.1021/acsomega.4c06879. eCollection 2024 Oct 15.
2
Computational repurposing of oncology drugs through off-target drug binding interactions from pharmacological databases.通过药理学数据库中的非靶标药物结合相互作用对肿瘤药物进行计算再利用。
Clin Transl Med. 2024 Apr;14(4):e1657. doi: 10.1002/ctm2.1657.
3

本文引用的文献

1
UniProt: the universal protein knowledgebase.通用蛋白质知识库:UniProt
Nucleic Acids Res. 2018 Mar 16;46(5):2699. doi: 10.1093/nar/gky092.
2
Choose and Use Your Chemical Probe Wisely to Explore Cancer Biology.明智地选择和使用你的化学探针以探索癌症生物学。
Cancer Cell. 2017 Jul 10;32(1):9-25. doi: 10.1016/j.ccell.2017.06.005.
3
A First-Time-in-Human Study of GSK2636771, a Phosphoinositide 3 Kinase Beta-Selective Inhibitor, in Patients with Advanced Solid Tumors.一项在晚期实体瘤患者中进行的 GSK2636771(一种磷酸肌醇 3 激酶β选择性抑制剂)首次人体研究。
Proteome-Wide Fragment-Based Ligand and Target Discovery.
基于片段的全蛋白质组配体与靶点发现
Isr J Chem. 2023 Mar;63(3-4). doi: 10.1002/ijch.202200098. Epub 2023 Feb 8.
4
Chemical Probes Review: Choosing the Right Path Towards Pharmacological Targets in Drug Discovery, Challenges and Future Perspectives.化学探针综述:在药物发现中选择药理学靶点的正确途径、挑战与未来展望。
Comb Chem High Throughput Screen. 2024;27(17):2544-2564. doi: 10.2174/0113862073283304231118155730.
5
Integrative GWAS and co-localisation analysis suggests novel genes associated with age-related multimorbidity.整合全基因组关联研究和共定位分析提示与年龄相关的多种疾病相关的新基因。
Sci Data. 2023 Sep 25;10(1):655. doi: 10.1038/s41597-023-02513-4.
6
Proteomics-Based Discovery of First-in-Class Chemical Probes for Programmed Cell Death Protein 2 (PDCD2).基于蛋白质组学的新型细胞程序性死亡蛋白 2(PDCD2)化学探针的发现。
Angew Chem Int Ed Engl. 2023 Oct 23;62(43):e202308292. doi: 10.1002/anie.202308292. Epub 2023 Sep 15.
7
Effectively utilizing publicly available databases for cancer target evaluation.有效利用公开可用数据库进行癌症靶点评估。
NAR Cancer. 2023 Jul 14;5(3):zcad035. doi: 10.1093/narcan/zcad035. eCollection 2023 Sep.
8
iTAG an optimized IMiD-induced degron for targeted protein degradation in human and murine cells.iTAG是一种经过优化的免疫调节药物(IMiD)诱导的降解子,用于在人和小鼠细胞中进行靶向蛋白质降解。
iScience. 2023 Jun 7;26(7):107059. doi: 10.1016/j.isci.2023.107059. eCollection 2023 Jul 21.
9
Target 2035 - an update on private sector contributions.《2035年目标——私营部门贡献情况更新》
RSC Med Chem. 2023 Mar 16;14(6):1002-1011. doi: 10.1039/d2md00441k. eCollection 2023 Jun 22.
10
Systematic literature review reveals suboptimal use of chemical probes in cell-based biomedical research.系统文献回顾揭示了细胞生物医学研究中化学探针的使用不理想。
Nat Commun. 2023 Jun 3;14(1):3228. doi: 10.1038/s41467-023-38952-1.
Clin Cancer Res. 2017 Oct 1;23(19):5981-5992. doi: 10.1158/1078-0432.CCR-17-0725. Epub 2017 Jun 23.
4
The druggable genome and support for target identification and validation in drug development.可成药基因组以及对药物研发中靶点识别与验证的支持。
Sci Transl Med. 2017 Mar 29;9(383). doi: 10.1126/scitranslmed.aag1166.
5
Phantom PAINS: Problems with the Utility of Alerts for Pan-Assay INterference CompoundS.幻痛:泛分析干扰化合物警报的效用问题
J Chem Inf Model. 2017 Mar 27;57(3):417-427. doi: 10.1021/acs.jcim.6b00465. Epub 2017 Feb 25.
6
The ChEMBL database in 2017.2017年的ChEMBL数据库。
Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. doi: 10.1093/nar/gkw1074. Epub 2016 Nov 28.
7
Evidence-Based and Quantitative Prioritization of Tool Compounds in Phenotypic Drug Discovery.基于证据的和定量的表型药物发现工具化合物优先级排序。
Cell Chem Biol. 2016 Jul 21;23(7):862-874. doi: 10.1016/j.chembiol.2016.05.016. Epub 2016 Jul 14.
8
canSAR: an updated cancer research and drug discovery knowledgebase.canSAR:一个更新的癌症研究与药物发现知识库。
Nucleic Acids Res. 2016 Jan 4;44(D1):D938-43. doi: 10.1093/nar/gkv1030. Epub 2015 Dec 15.
9
E7449: A dual inhibitor of PARP1/2 and tankyrase1/2 inhibits growth of DNA repair deficient tumors and antagonizes Wnt signaling.E7449:一种PARP1/2和端锚聚合酶1/2的双重抑制剂可抑制DNA修复缺陷肿瘤的生长并拮抗Wnt信号传导。
Oncotarget. 2015 Dec 1;6(38):41307-23. doi: 10.18632/oncotarget.5846.
10
BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology.2015年的BindingDB:一个用于药物化学、计算化学和系统药理学的公共数据库。
Nucleic Acids Res. 2016 Jan 4;44(D1):D1045-53. doi: 10.1093/nar/gkv1072. Epub 2015 Oct 19.